| Autor: |
Nasim F; 1 Mayo Clinic, Rochester, MN., Poterucha JT; 1 Mayo Clinic, Rochester, MN., Daniels LM; 1 Mayo Clinic, Rochester, MN., Park JG; 1 Mayo Clinic, Rochester, MN., Seelhammer TG; 1 Mayo Clinic, Rochester, MN., Bohman JK; 1 Mayo Clinic, Rochester, MN., Friedrich TP; 1 Mayo Clinic, Rochester, MN., Blau CL; 1 Mayo Clinic, Rochester, MN., Elmer JL; 1 Mayo Clinic, Rochester, MN., Schears GJ; 1 Mayo Clinic, Rochester, MN. |
| Abstrakt: |
Extracorporeal membrane oxygenation (ECMO) is used to treat severe hypoxemic respiratory failure and as a rescue therapy for patients with cardiopulmonary arrest within a narrow window of time. A failure modes and effects analysis (FMEA) was conducted to analyze the clinical and operational processes leading to delays in initiating ECMO. FMEA determined these highest-risk failure modes that were contributing to process failure: (1) ECMO candidacy not determined in time, (2) no or incomplete evaluation for ECMO prior to consult or arrest, (3) ECMO team not immediately available, and (4) cannulation not completed in time. When implemented collectively, a total of 4 interventions addressed more than 95% of the system failures. These interventions were (1) ECMO response pager held by a team required for decision, (2) distribution of institutionally defined inclusion/exclusion criteria, (3) educational training for clinicians consulting the ECMO team, and (4) establishment of a mobile ECMO insertion cart. |
